N-[[6-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]-5,7-dihydrocyclopenta[c]pyridin-6-yl]methyl]acetamide
C23H21N5O — CID 126616914
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[6-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]-5,7-dihydrocyclopenta[c]pyridin-6-yl]methyl]acetamide
N-[[6-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]-5,7-dihydrocyclopenta[c]pyridin-6-yl]methyl]acetamide (PubChem CID 126616914) has the molecular formula C23H21N5O and a molecular weight of 383.46 g/mol. Its IUPAC name is N-[[6-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]-5,7-dihydrocyclopenta[c]pyridin-6-yl]methyl]acetamide.
Molecular Properties
| Compound Name | N-[[6-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]-5,7-dihydrocyclopenta[c]pyridin-6-yl]methyl]acetamide |
|---|---|
| PubChem CID | 126616914 |
| Molecular Formula | C23H21N5O |
| Molecular Weight | 383.46 g/mol |
| Exact Mass | 383.17 |
| IUPAC Name | N-[[6-[3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]-5,7-dihydrocyclopenta[c]pyridin-6-yl]methyl]acetamide |
| SMILES | CC(=O)NCC1(c2cccc(-c3ncnc4[nH]ccc34)c2)Cc2ccncc2C1 |
| InChI | InChI=1S/C23H21N5O/c1-15(29)26-13-23(10-17-5-7-24-12-18(17)11-23)19-4-2-3-16(9-19)21-20-6-8-25-22(20)28-14-27-21/h2-9,12,14H,10-11,13H2,1H3,(H,26,29)(H,25,27,28) |
| InChIKey | SBJYBFMDOHOLKL-UHFFFAOYSA-N |
| XLogP | 3.19 |
| TPSA | 83.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 383.46 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126616914 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.